- Filed
- Nov 14, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2022 · Nov 9, 2022 | 105.64M sh |
| Short Term Investments | Q3 2022 · Sep 30, 2022 | $165.74M |
| Short Term Investments | Q3 2022 · Dec 31, 2021 | $0 |
| Cash And Equivalents | Q3 2022 · Sep 30, 2022 | $125.78M |
| Cash And Equivalents | Q3 2022 · Dec 31, 2021 | $238.82M |
| Current Liabilities | Q3 2022 · Sep 30, 2022 | $16.61M |
| Current Liabilities | Q3 2022 · Dec 31, 2021 | $7.98M |
| Total Liabilities | Q3 2022 · Sep 30, 2022 | $16.61M |
| Total Liabilities | Q3 2022 · Dec 31, 2021 | $8.05M |
| Current Assets | Q3 2022 · Sep 30, 2022 | $296.23M |
| Current Assets | Q3 2022 · Dec 31, 2021 | $243.85M |
| Total Assets | Q3 2022 · Sep 30, 2022 | $325.69M |
| Total Assets | Q3 2022 · Dec 31, 2021 | $263.26M |
| Shares Diluted | Q3 2022 · Sep 30, 2021 | 90.12M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2021 | 68.32M sh |
| Dividends Paid | Q3 2022 · Sep 30, 2021 | $0 |
| Capex restated | Q3 2022 · Sep 30, 2021 | $6.32M |
| Operating Cash Flow restated | Q3 2022 · Sep 30, 2021 | −$33.17M |
| Eps Diluted | Q3 2022 · Sep 30, 2021 | −$0.19 |
| Eps Diluted | Q3 2022 · Sep 30, 2021 | −$0.46 |
| Eps Basic | Q3 2022 · Sep 30, 2021 | −$0.19 |
| Eps Basic | Q3 2022 · Sep 30, 2021 | −$0.46 |
| Sga Expense | Q3 2022 · Sep 30, 2021 | $4.03M |
| Sga Expense | Q3 2022 · Sep 30, 2021 | $7.44M |
| Rd Expense | Q3 2022 · Sep 30, 2021 | $13M |
| Rd Expense | Q3 2022 · Sep 30, 2021 | $23.97M |
| Net Income | Q3 2022 · Sep 30, 2021 | −$17.12M |
| Net Income | Q3 2022 · Sep 30, 2021 | −$31.71M |
| Net Income | Q3 2022 · Jun 30, 2021 | −$8.8M |
| Net Income | Q3 2022 · Mar 31, 2021 | −$5.78M |
| Operating Income | Q3 2022 · Sep 30, 2021 | −$17.03M |
| Operating Income | Q3 2022 · Sep 30, 2021 | −$31.42M |